Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis, Relapsing-Remitting

Explore clinical trials studying Multiple Sclerosis, Relapsing-Remitting. Study availability and eligibility vary by location and protocol.

464 public trials 49 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis, Relapsing-Remitting trial results

Completed

Hematopoietic Stem Cell Transplantation for Treatment of Multiple Sclerosis in Sweden

NCT05029206

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Sahlgrenska University Hospital Gothenburg, Sweden
  • Linköping University Hospital Linköping, Sweden
  • Skåne University Hospital Lund, Sweden
  • Örebro University Hospital Örebro, Sweden
View Trial Details
Completed

Effectiveness and Safety of Generic Delayed-Release Dimethyl Fumarate (Sclera® or Marovarex ®, Hikma) in Routine Medical Practice in the Treatment of Relapsing-Remitting Multiple Sclerosis in MENA Region

NCT04468165

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +9 more
Locations
  • CHU Frantz FANON Blida, Algeria
  • Nedir Mohamed Hospital Tizi Ouzou, Algeria
  • New University Hospital Alexandria, Egypt
  • Demerdash hospital (Ain Shams University) Cairo, Egypt
View Trial Details

Related conditions